Innovations in Sickle Cell Disease: How the Latest Advances May Impact Clinical Decision-making – Rapid Response From Amsterdam

0.75 CME
45 MINS
$0 FEE
SAVE
J206

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.


Support Statement

This activity is supported by an educational grant from Global Blood Therapeutics.


Target Audience

The intended audience for this activity is hematologists and other health care professionals involved in the management of patients with sickle cell disease (SCD).


Learning Objectives

Upon successful completion of this activity, participants should be better able to evaluate the latest advances regarding new or emerging disease-modifying options for patients with SCD and the associated clinical implications.


Activity Chair

Jeremie H. Estepp, MD
Assistant Member
Departments of Hematology and Pathology
St. Jude Children's Research Hospital
Memphis, TN


Faculty

Biree Andemariam, MD
Associate Professor of Medicine
Director, New England Sickle Cell Institute
University of Connecticut
Farmington, CT

Jo Howard, MB BChir
Consultant and Lead Hematologist
Guy’s and St Thomas’ NHS Foundation Trust
London, UK

Mark C. Walters, MD
Jordan Family Director, Blood and Marrow Program
Professor of Pediatrics, UCSF School of Medicine
University of California San Francisco
San Francisco, CA


Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, June 25, 2019, to June 24, 2020.


How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objective, answer the pretest questions, review the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.


Activity Chair and Faculty report the following relationships

Biree Andemariam, MD
Consulting Fee: Bluebird Bio, Emmaus Life Sciences, Ironwood, Novartis, Pfizer
Contracted Research: Imara
Data Safety and Monitoring Board: Global Blood Therapeutics

Jeremie H. Estepp, MD
Consulting Fee: Daiichi Sankyo, Global Blood Therapeutics
Contracted Research: Daiichi Sankyo, Eli Lilly, Global Blood Therapeutics, Genentech, Pfizer

Jo Howard, MB BChir
Consulting Fee: Global Blood Therapeutics, Imara
Contracted Research: Global Blood Therapeutics
Travel grant: Imara, Resonance Health

Mark C. Walters, MD
Consulting Fee: AllCells, Editas, TruCode
Contracted Research: Bioverativ/Sanofi, Bluebird Bio, Sangamo Biotherapeutics
Ownership Interest: AllCells
Medical Director: AllCells, ViaCord Processing Lab


Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.


Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com